5Honeylourne D, Baner jee D, Andrews J, et al. Concentrations of gatifloxacin in plasma. and pulmonary compartments following a single 400rug oral in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother, 2001, 48(1) :63. 被引量：1
6Mitsuyoshi N, Toshihiko U, Kazuhiro K, et al. Singleand multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans. Antimicrob Agents Chemother, 1995, 39(12) :2635. 被引量：1
8Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia:diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754 被引量：1
9Dunbar LM,Wunderink RG,Habib MP,et al.High-dose,short-course levofloxacin for community-acquired pneumonia:a new treatment paradigm.Clin Infect Dis,2003,7:752-760 被引量：1
10Finch R,Schurmann D,Collins O,et al.Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment.Antimicrob Agents Chemother,2002,46,1746-1754 被引量：1
